Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial. (Q39635163)
Jump to navigation
Jump to search
scientific article published on 16 June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial. |
scientific article published on 16 June 2016 |
Statements
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial (English)
Lisa Pleyer
Petra Obrtlíková
Tomáš Kozák
Michael Steurer
Johannes Andel
Sonja Burgstaller
Eva Mikušková
Thomas Nösslinger
Tomáš Papajík
Miriam Ladická
Michael Girschikofsky
Mikuláš Hrubiško
Ulrich Jäger
Michael Fridrik
Martin Pecherstorfer
Eva Králiková
Cristina Burcoveanu
Emil Spasov
Andreas Petzer
Georgi Mihaylov
Julian Raynov
Horst Oexle
August Zabernigg
Emília Flochová
Stanislav Palášthy
Olga Stehlíková
Michael Doubek
Petra Altenhofer
Thomas Melchardt
Anton Klingler